14 full blood count rows
Separate FBC line items (for example haemoglobin, MCV, platelets) rather than one grouped FBC result.
Listen Health is one of the closest products to Hemexa in Australia: Healius collection, no GP visit required to get tested, and a member dashboard. Their site publishes an Advanced Whole-Body Membership at $495/year ("less than $10 per week") testing "90+ biomarkers tested annually", plus a "Choose My Own Tests" option from $40 per test across a "120+ biomarkers" catalogue. They recommend testing once a year, with further retesting optional and discounted.
Hemexa is $99.92/month billed annually (AU$1,199/year) all-in: GP-reviewed requests and results, 2,000+ Healius Pathology collection centres nationwide, 76–80 signature markers on baseline, an included six-month retest on 12 fast-moving markers, a health-system dashboard, a personalised plan after every panel, self-serve pathology PDF imports, a health-event timeline, member-managed conditions, tracking for supplements, peptides, and over-the-counter medications tied to your blood, and genetic context from a 23andMe or AncestryDNA file you already have.
Your baseline panel covers 76 signature markers for men and 80 for women. The difference is 4 female hormone markers. Fast-moving markers are drawn again on your included six-month retest.
Listen Health and Hemexa both exclusively use Healius Pathology for collection, and both issue a pathology request without an in-person GP visit. Listen's FAQ says "We recommend testing once per year", with further testing available as discounted, paid retesting.
Hemexa builds a six-month retest into every membership, itemises every marker on the baseline panel, and publishes named thresholds for urgent results. Listen's consent policy says it does not clinically review or interpret every result: critical values go to its Chief Medical Officer, and other results are released as reported by the laboratory. Both are Healius-collected memberships; the difference is what is already included, and how results are reviewed.
Listen Health markets "90+ biomarkers tested annually" on its membership. On /what-we-test, filtering to "Advanced Whole Body Membership" (data-filter=standard) shows 83 unique named rows as at 2 September 2026. That is what the public page lists today, not an independent recount of every analyte on the lab form.
Separate FBC line items (for example haemoglobin, MCV, platelets) rather than one grouped FBC result.
A dipstick screen (glucose, leukocytes, nitrites, pH, blood, bacteria, and related fields), not a quantitative urine albumin/creatinine ratio.
Calculated or ratio rows such as TC/HDL, TG/HDL, and ApoB/ApoA1 ratio. Both providers count ratios toward their headline totals.
A biological-age score derived from the panel, not a separate lab assay.
The remaining rows are individual blood assays on the membership filter. Expensive or specialised tests are tagged as Add-Ons on the same page, including Lp(a), active B12, folate, thyroid antibodies, genetics, heavy metals, AMH, and semen analysis.
Hemexa's annual baseline is a named list of 76–80 signature markers, itemised and published, including ApoB, Lp(a), and urine ACR. The question is not only how high the headline number is, but what assays, ratios, and screens are already in the membership price.
On the same /what-we-test page, membership versus premium tagging does not line up for ApoB:
data-filter="standard"data-plans="premium"A ratio that requires ApoB cannot be produced if ApoB was not measured. That is how the page is tagged today. Confirm on their site.
Listen's membership filter includes a urine dipstick screen: glucose, leukocytes, nitrites, pH, blood, bacteria, and related dipstick fields. That is a qualitative screen, useful for infection or gross abnormalities.
The kidney-staging test, urine albumin/creatinine ratio (ACR), is on Listen's add-on list as "Microalbumin, Urine". It is not on the membership filter we counted above.
Hemexa's annual baseline includes urine ACR (albumin, creatinine, and the ACR ratio). Kidney Health Australia's Kidney Health Check pairs eGFR with urine ACR for people at risk. Hemexa includes both on the baseline panel.
Listen urine rows checked on /what-we-test, 2 September 2026. Hemexa panel from markers.frequency (annual and biannual).
Listen Health and Hemexa both coordinate testing through the Healius Pathology network, and both skip an in-person GP visit. Listen arranges a phone call for critical life-threatening values. Hemexa reviews every returned panel against published thresholds and holds urgent results until you have been contacted. The other difference shows up after your first panel: what your annual price already includes.
Listen's FAQ says "We recommend testing once per year" and describes retesting as "access to discounted re-testing and add-on panels anytime", priced separately and not published. Hemexa's membership includes a six-month retest on fast-moving markers at no extra cost, so a mid-year check is already paid for.
Listen publishes two doors: the $495/year Advanced Whole-Body Membership and a "Choose My Own Tests" menu "from $40" per test, plus add-ons (their terms note "some services and tests may require additional payment beyond standard membership pricing"). Hemexa is one annual price with baseline, retest, dashboard, plan, stack insights, conditions, timeline, and DNA file import included, and nothing further to buy.
Listen's membership is built around one annual draw, with further testing optional and paid. Hemexa is built around two draws a year: your annual baseline plus an included six-month retest, so your dashboard has a second data point without an extra order.
Listen Health publishes two ways to test and Hemexa publishes one. Comparing the structure, not just the headline number, is the clearest way to see what each actually costs across a year.
Every Listen Health figure above is quoted from listenhealth.com.au, /faq, /what-we-test, and /terms-of-service as at 2 September 2026. Some third-party listings still cite older $690 and $1,090 tiers; those do not match the live site. Confirm current pricing on their site.
$1,199/year
Listen recommends testing once per year and prices retesting as an optional, discounted extra. Hemexa builds a six-month retest into membership, so a mid-year check does not mean a second purchase decision.
Your annual baseline covers 76–80 signature markers across 16 body systems. Women receive four additional hormone markers: estradiol, FSH, LH and progesterone. Listen's membership filter on /what-we-test lists 83 named rows toward "90+", including 14 FBC lines, 9 urine dipstick fields, 11 ratios/derived values, and a calculated biological age. Lp(a), active B12, folate, thyroid antibodies, genetics, heavy metals, AMH, semen analysis, and urine ACR ("Microalbumin, Urine") are add-ons. ApoB is tagged premium-only while an ApoB/ApoA1 ratio sits on the standard filter. Hemexa's baseline is a named list and includes ApoB, Lp(a), and urine ACR.
Listen's FAQ promises "an immediate phone call from one of our doctors" for critical life-threatening results. Its Consent to Testing & Clinical Oversight Policy, updated 9 July 2026, says it does not clinically review or interpret every result: critical values are escalated to its Chief Medical Officer, and other results are made available as reported by the laboratory. Hemexa publishes named tier 1 and tier 2 marker thresholds, a registered Australian GP reviews requests and returned results, and tier 1 values are held until same-day contact is confirmed.
Hemexa is $99.92/month billed annually (AU$1,199/year), covering baseline, retest, dashboard, plan, imports, conditions, timeline, stack insights, and DNA file import. There is no membership-plus-menu structure and no add-on priced on top, so the number you see when you join is the number you pay.
Listen and Hemexa both store lab results in an app. The useful question is what else sits next to those results: the stack you take, the conditions you live with, the events that change how blood should be read, and any DNA file you already have.
Hemexa lets you log supplements, peptides, and over-the-counter medications, then snapshots that stack against each blood draw so you can see whether markers moved. Listen's public pages describe diet and lifestyle recommendations and advise pausing non-essential supplements before the draw. They do not describe a member-logged stack, peptide tracking, or insights tied to what you actually take.
Hemexa has a member-managed conditions list that feeds your health plan. Listen asks a health questionnaire at signup and tracks biomarkers linked to common conditions. A member-managed problem list is not described on its public pages.
Hemexa has two timelines: past pathology PDFs after your first baseline, and a health-event timeline for dated things such as diagnoses, surgeries, and medication changes. Listen tracks lab trends over time and lists "Upload past results". A health-event timeline is not described.
Hemexa does not sell a DNA test. If you already have a 23andMe or AncestryDNA raw file, you can import it and Hemexa adds genetic context to markers such as Lp(a) and iron. Listen sells genetic add-on lab tests, including MTHFR sequencing, as paid extras. Importing a consumer DNA file is not described on its public pages.
A side-by-side for Australians comparing Listen Health with other options. Look past the headline price: whether a retest is included, whether every result is GP-reviewed, and whether you can log your stack, conditions, timeline, and DNA next to the results.
| Feature | Listen Health | Everlab | Vively | Function Health | Hemexa |
|---|---|---|---|---|---|
| Available in Australia | Yes (Healius network) | Yes (Australia-wide) | Yes | No, not available in Australia | Yes |
| Published price (from) | $495/yr membership, or from $40 per test | $299 Health Baseline; plans $900 to $2,700 | From $99 per test (Baseline Health Check) | Not sold in Australia | $1,199/yr all-in |
| Baseline panel markers | 90+ on membership (83 named rows: 14 FBC, 9 urine dipstick, 11 ratios/derived, 1 biological age); 120+ in pay-per-test catalogue | Over 65 key blood biomarkers (Full Advanced Bloods) | 70+ key markers (Baseline Health Check) | Not available in Australia | 76–80 baseline, named list |
| ApoB on membership panel | No; ApoB is premium-only (ApoB/ApoA1 ratio is on standard membership filter) | See provider site | See provider site | Not available in Australia | Yes, included on baseline |
| Lp(a) on membership panel | No; listed as an add-on on /what-we-test | See provider site | See provider site | Not available in Australia | Yes, included on baseline |
| Urine ACR on membership panel | No; dipstick screen on membership, "Microalbumin, Urine" is an add-on | See provider site | See provider site | Not available in Australia | Yes, urine ACR on annual baseline |
| Full marker list published | Yes, membership vs add-ons on their test list | See provider site | See provider site | Not available in Australia | Yes, every marker itemised and filterable |
| Six-month retest included | No; annual draw recommended, retesting discounted and optional | Priced per plan or scan | Each test purchased separately | Not available in Australia | Yes, included |
| Australian pathology network | 2,000+ Healius Pathology locations (exclusive partner) | 1,850+ vetted diagnostic facilities | 4,000 test centres | None, United States laboratories only | 2,000+ Healius Pathology centres nationwide |
| Clinical review of results | Critical values only; other results released as reported by the lab | Results analysed by Everlab doctors | AHPRA-registered nurse review | Not available in Australia | GP reviews requests and results |
| Named critical-value thresholds published | No, one sentence: "immediate phone call" | Not published | Not published | Not available in Australia | Yes, named tier 1 and tier 2 thresholds |
| Health-system dashboard | Yes, "lifetime access to your data" | Yes (Everlab app) | Yes (app) | Not available in Australia | Systems, scores, and trends |
| Personalised health plan | Diet and lifestyle recommendations | Yes (doctor-led) | Yes (90-day action plan) | Not available in Australia | Yes, after every panel |
| Bring in past pathology from other labs | "Upload past results" listed; workflow not described | Concierge (team requests records) | No | Not available in Australia | Yes, upload past PDFs |
| Supplement, peptide, and OTC tracking | Not described (diet and lifestyle recs; pause supplements before the draw) | Doctor-led in intervention plans | Limited | Not available in Australia | Log what you take and see if blood moved |
| Member-managed conditions | Questionnaire at signup; no member list described | See provider site | See provider site | Not available in Australia | Yes, feeds your health plan |
| Health event timeline | Lab trends; event timeline not described | See provider site | See provider site | Not available in Australia | Yes, dated events plus imported PDFs |
| Import existing DNA file | Sells genetic add-on tests; file import not described | Genetic tests as add-ons | Not described | Not available in Australia | Yes, 23andMe or AncestryDNA |
| Primary model | Annual membership + pay-per-test menu | Longevity clinic programs | CGM + metabolic baseline | US-only subscription | AU biomarker membership |
Listen Health figures checked 2 September 2026 on listenhealth.com.au, including /what-we-test, /faq, /how-it-works, and the Consent to Testing & Clinical Oversight Policy. Other competitor figures in this table are each provider's own published details as at July 2026. Confirm current details on each provider website before you decide.
Listen Health publishes a $495/year membership or from $40 a test. Hemexa is for Australians who want that retest already included, a GP review of every result, named critical-value thresholds, every baseline marker itemised, and the context next to those results (your stack, conditions, timeline, and DNA file), all at $99.92/month billed annually (AU$1,199/year) with nothing further to buy.
No provider is right for everyone. Choose based on what you actually want from your next blood test or membership, then join Hemexa if the wedge fits.
Hemexa is a preventative health membership and health intelligence platform. It does not provide medical advice, diagnosis, treatment, or emergency care. Always discuss results and health decisions with your GP or qualified clinician. Read our health disclaimer.
Start your membership in the member app. Or browse all 76–80 markers before you decide.